Concord Biotech

{
  "main_header": {
    "sid": 10038977,
    "name": "Concord Biotech",
    "stock_name": "Concord Biotech",
    "full_name": "Concord Biotech Ltd",
    "name_url": "stocks-analysis/concord-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,353.85",
    "chg": 8.55,
    "chgp": "0.64%",
    "dir": 1,
    "prev_price": "1,345.30",
    "mcapval": "14,114.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543960,
    "symbol": "CONCORDBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE338H01029",
    "curr_date": "Jun 12, 03:30 PM",
    "curr_time": "01:55 AM",
    "last_traded_at": "Jun 12, 03:30 PM IST",
    "bse_nse_vol": "3.96 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 12, 2026",
    "traded_date_str": "2026 06 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/concord-biotech-10038977-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Concord Biotech Upgraded to Hold as Technicals Improve Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-upgraded-to-hold-as-technicals-improve-despite-flat-financials-4046096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_mojoScore_4046096.png",
        "date": "2026-06-11 08:33:31",
        "description": "Concord Biotech Ltd has seen its investment rating upgraded from Sell to Hold as of 10 June 2026, reflecting a nuanced improvement in its technical outlook alongside stable financial metrics. Despite challenges in long-term growth and valuation concerns, the company’s enhanced technical indicators and solid management efficiency have prompted a reassessment of its market stance."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Signal Mild Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4045971",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4045971.png",
        "date": "2026-06-11 08:05:31",
        "description": "Concord Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a 4.35% gain on 11 Jun 2026. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and volume trends suggest cautious optimism for investors in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Concord Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/concord-biotech-ltd-is-rated-sell-4044075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_mojoScore_4044075.png",
        "date": "2026-06-10 10:10:05",
        "description": "Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Concord Biotech Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4043416",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4043416.png",
        "date": "2026-06-10 08:06:50",
        "description": "Concord Biotech Ltd has exhibited a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways consolidation phase. Despite a robust day change of 6.18%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4040283",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4040283.png",
        "date": "2026-06-09 08:05:31",
        "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid mixed signals from key momentum and trend metrics."
      },
      {
        "title": "Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-4035340",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_technicaldot_4035340.png",
        "date": "2026-06-04 08:05:33",
        "description": "Concord Biotech Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent day gain of 2.86%, the stock remains under pressure over longer timeframes, with technical indicators offering a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Concord Biotech Ltd Sees Surge in High-Value Trading Amid Positive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-sees-surge-in-high-value-trading-amid-positive-momentum-4033361",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_most_active_equities_by_value_4033361.png",
        "date": "2026-06-03 10:00:40",
        "description": "Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 3 June 2026. The stock demonstrated strong price gains and significant institutional interest, reflecting growing investor confidence despite a recent downgrade in its Mojo Grade."
      },
      {
        "title": "Concord Biotech Ltd Surges 7.99% to Day's High of Rs 1255.15 — Outperforms Sector by 6.91 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-hits-intraday-high-with-799-surge-on-3-june-2026-4033392",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_priceRelatedfactors_4033392.png",
        "date": "2026-06-03 09:46:42",
        "description": "While the Sensex declined sharply by 1.09% on 03 Jun 2026, Concord Biotech Ltd surged 7.99%, marking a standout session with a 6.91 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong intraday gain rewrites the short-term narrative for the small-cap stock, which has now recorded three consecutive days of gains, accumulating an 18.8% return in that period."
      },
      {
        "title": "High-Beta Concord Biotech Ltd Surges 5.85% at Open — A Closer Look at Whether Momentum Can Hold",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/concord-biotech-ltd-opens-strong-with-significant-gap-up-on-3-june-2026-4033379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ConcordBiotechL_gapup_4033379.png",
        "date": "2026-06-03 09:45:51",
        "description": ""
      }
    ],
    "total": 416,
    "sid": "10038977",
    "stock_news_url": "https://www.marketsmojo.com/news/concord-biotech-10038977"
  },
  "announcements": [
    {
      "caption": "Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Tofacitinib Tablets 5 Mg And 10 Mg",
      "datetime": "10-Jun-2026",
      "details": "We are pleased to inform that the Company has received approval from USFDA for its ANDA for Tofacitinib Tablets 5 mg and 10 mg.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-Jun-2026",
      "details": "Transcript of Q4 & FY26 Earnings call held on June 01 2026",
      "source": "BSE"
    },
    {
      "caption": "Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval For Mycophenolate Mofetil For Oral Suspension USP 200 Mg/Ml",
      "datetime": "02-Jun-2026",
      "details": "We are pleased to inform that the Company has received approval from USFDA for its ANDA for Mycophenolate Mofetil for Oral Suspension USP 200 mg/mL.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Concord Biotech Ltd has declared <strong>1070%</strong> dividend, ex-date: 03 Sep 25",
          "dt": "2025-09-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Concord Biotech Upgraded to Hold as Technicals Improve Despite Flat Financials

2026-06-11 08:33:31

Concord Biotech Ltd has seen its investment rating upgraded from Sell to Hold as of 10 June 2026, reflecting a nuanced improvement in its technical outlook alongside stable financial metrics. Despite challenges in long-term growth and valuation concerns, the company’s enhanced technical indicators and solid management efficiency have prompted a reassessment of its market stance.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Signal Mild Bullish Outlook

2026-06-11 08:05:31

Concord Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a 4.35% gain on 11 Jun 2026. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and volume trends suggest cautious optimism for investors in the pharmaceuticals and biotechnology sector.

Read full news article

Concord Biotech Ltd is Rated Sell

2026-06-10 10:10:05

Concord Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Concord Biotech Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-06-10 08:06:50

Concord Biotech Ltd has exhibited a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a transition from a mildly bearish trend to a sideways consolidation phase. Despite a robust day change of 6.18%, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-09 08:05:31

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid mixed signals from key momentum and trend metrics.

Read full news article

Concord Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-04 08:05:33

Concord Biotech Ltd has exhibited a notable shift in price momentum, moving from a mildly bearish technical stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent day gain of 2.86%, the stock remains under pressure over longer timeframes, with technical indicators offering a nuanced outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Concord Biotech Ltd Sees Surge in High-Value Trading Amid Positive Momentum

2026-06-03 10:00:40

Concord Biotech Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 3 June 2026. The stock demonstrated strong price gains and significant institutional interest, reflecting growing investor confidence despite a recent downgrade in its Mojo Grade.

Read full news article

Concord Biotech Ltd Surges 7.99% to Day's High of Rs 1255.15 — Outperforms Sector by 6.91 Percentage Points

2026-06-03 09:46:42

While the Sensex declined sharply by 1.09% on 03 Jun 2026, Concord Biotech Ltd surged 7.99%, marking a standout session with a 6.91 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong intraday gain rewrites the short-term narrative for the small-cap stock, which has now recorded three consecutive days of gains, accumulating an 18.8% return in that period.

Read full news article

High-Beta Concord Biotech Ltd Surges 5.85% at Open — A Closer Look at Whether Momentum Can Hold

2026-06-03 09:45:51

Read full news article

View All News